Cargando…

Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Yap, Christina, Billingham, Lucinda, Pettitt, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287812/ http://dx.doi.org/10.1186/1745-6215-12-S1-A91

Ejemplares similares

Screened selection design for randomised phase II oncology trials: an example in chronic lymphocytic leukaemia
por: Yap, Christina, et al.
Publicado: (2013)

Implementation of adaptive dose-finding designs in two early phase haematological trials: clinical, operational, and methodological challenges
por: Yap, Christina, et al.
Publicado: (2013)

Dose transition pathways: a design, analysis and operational tool for dose-finding trials using model-based designs
por: Yap, Christina, et al.
Publicado: (2015)

Using meta-analysis of Phase II trials to predict Phase III trial results
por: Burke, Danielle, et al.
Publicado: (2013)

Health technology assessment: oncology drugs with orphan designation as an example
por: Wild, Claudia
Publicado: (2010)

Using a Bayesian approach with reverse philosophy to design clinical trials in rare diseases
por: Billingham, Lucinda, et al.
Publicado: (2013)

Crossing survival curves: alternatives to the log-rank test
por: Bouliotis, George, et al.
Publicado: (2011)

Comparison of a frequentist and Bayesian response-adaptive randomisation approach in multi-stage phase II selection trials with multiple experimental arms
por: Yap, Christina, et al.
Publicado: (2015)

DESIGN OF THE MYECHILD TRIAL, AN INTERNATIONAL RANDOMISED PHASE III CLINICAL TRIAL IN CHILDREN WITH ACUTE MYELOID LEUKAEMIA INCORPORATING AN EMBEDDED DOSE FINDING STUDY
por: Houlton, Aimee, et al.
Publicado: (2015)

Evaluation of methods to adjust for treatment switching in clinical trials
por: Fox, Richard, et al.
Publicado: (2011)

Statistical issues in the design of randomised surgical trials: a practical example of the possible solutions
por: Marshall, Helen, et al.
Publicado: (2011)

Pro’s and con’s of the stepped wedge design in cluster randomised trials of quality improvement interventions: two current examples
por: Dreischulte, Tobias, et al.
Publicado: (2013)

The design of a multi-arm multi-stage (MAMS) phase III randomised controlled trial comparing alternative regimens for escalating (COMPARE) treatment of intermediate and high-risk oropharyngeal cancer with reflections on the complications of introducing a new experimental ARM
por: Gaunt, Piers, et al.
Publicado: (2015)

Stratified medicine in practice: review of predictive biomarkers in European Medicines Agency (EMA) indications
por: Malottki, Kinga, et al.
Publicado: (2011)

Practical implementation of an adaptive phase I/II design in chronic myeloid leukaemia: evaluating both efficacy and toxicity using the EffTox design
por: Khan, Josephine, et al.
Publicado: (2013)

Evidence synthesis in trial design: an example from the neurosciences
por: Egan, Kieren, et al.
Publicado: (2013)

A framework for the design and analysis of phase III randomised trials in uncommon diseases
por: Parmar, Mahesh, et al.
Publicado: (2015)

Modelling clinical trial recruitment using poisson processes
por: Brock, Kristian, et al.
Publicado: (2015)

Design choices for small-scale phase II trials with non-inferiority (NI) intention
por: Sun, Hong, et al.
Publicado: (2011)

An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
por: Stallard, Nigel
Publicado: (2011)

Comparison of anticipated and actual control group outcome in randomised trials in paediatric oncology provides evidence that non-randomised studies are biased in favour of the novel treatment
por: Moroz, Veronica, et al.
Publicado: (2011)

Conducting a randomised trial during an influenza pandemic: an example of a trial set up and ‘hibernated’ ready to activate and recruit within 4 weeks
por: Brittain, Clare, et al.
Publicado: (2015)

A systematic review of the use of an expertise-based randomised trial design
por: Cook, Jonathan, et al.
Publicado: (2015)

Design, analysis and reporting of active-control randomised trials: a systematic review
por: Odondi, Lang'o, et al.
Publicado: (2013)

Methodological challenges designing pragmatic, multi-centre randomised controlled trials in critical care
por: MacLennan, Graeme, et al.
Publicado: (2013)

Combining pharmacophore- and MD-based modelling for phase II metabolism prediction
por: Rakers, Christin, et al.
Publicado: (2014)

A series of decision-theoretic phase II trials of related treatments
por: Hee, Siew Wan, et al.
Publicado: (2013)

Comparing active treatments at phase II: using multiple criteria to find the optimal treatment to take forward to phase III
por: Sweeting, Michael, et al.
Publicado: (2013)

Adrenal masses in oncology patients
por: Reznek, Rodney H
Publicado: (2014)

Global challenges in oncologic imaging
por: Hricak, Hedvig
Publicado: (2014)

Why we should have more collaboration on HTA in Europe: the example of sofosbuvir
por: Schelleman, Hedi, et al.
Publicado: (2015)

Using continuous data on tumour measurements to improve inference in phase II cancer studies
por: Wason, James, et al.
Publicado: (2013)

Application of next generation sequencing in oncology
por: Meyer, Brian
Publicado: (2014)

Development of novel oncology biomarkers for cancer
por: Yoganathan, Nathan
Publicado: (2014)

Incidental findings in the oncology patient: ovaries
por: Forstner, Rosemarie
Publicado: (2014)

Incidental lesion in oncology patients: kidneys
por: Sohaib, Aslam
Publicado: (2014)

Incidental findings in the oncology patient: liver
por: Schima, Wolfgang
Publicado: (2014)

Using the UK renal registry for a clinical trial in dialysis patients: the example of SIMPLIFIED
por: Bond, Simon, et al.
Publicado: (2015)

Signal transduction in T lymphocytes
por: Cantrell, D
Publicado: (2005)

Longitudinal mediation in the PACE randomised clinical trial of rehabilitative treatments for chronic fatigue syndrome: modelling and design considerations
por: Goldsmith, Kimberley, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_08rn7no2in868buhofbcrlu2ha